IRulya Therapeutics Inc. - 10-Q Filing
IRulya Therapeutics reports Q3 2026 results following Orphai Therapeutics acquisition and ongoing European Investment Bank debt servicing.
Tickers: $QNCX
More Regulatory news
- Andersen Group Inc. - 8-K Filing
- AltEnergy Acquisition Corp - 10-Q Filing
- AtlasClear Holdings, Inc. - 10-Q Filing
- Amerant Bancorp Inc. - 8-K Filing
- iShares Gold Trust Micro - 8-K Filing
- iShares Silver Trust - 8-K Filing
- ISHARES GOLD TRUST - 8-K Filing
- Tradewinds Universal - 8-K Filing
- iShares Bitcoin Trust ETF - 8-K Filing
- iShares S&P GSCI Commodity-Indexed Trust - 8-K Filing